Flowers Foods hit by weak demand, guidance cut, and Tastykake sale plan
Q2 miss and 2026 guidance cut Flowers Foods reported Q2 sales down 4% to $1.19B, missing estimates, and cut full-year 2026 sales and EPS guidance below consensus. Management blamed pressured household budgets, shifting buying habits, and tough competition in fresh bread. The stock fell sharply as investors lowered expectations for future profits.
This is the core negative event that directly caused the stock to drop and reset expectations.
Weak demand from value-conscious consumers and GLP-1 drugs Palm Valley Capital noted that demand for Flowers' bread and bakery products is being hurt by cost-conscious shoppers and the growing use of GLP-1 weight-loss medications. These trends reduce how much bread people buy, pressuring sales and profits. The fund expects near-term conditions to stay challenging.
It explains a deeper, ongoing demand problem that affects future revenue, not just one quarter.
Exploring sale of Tastykake unit for about $350 million Flowers Foods is exploring a sale of its Tastykake division, which could bring in around $350 million. The move fits its plan to shed non-core brands and focus on higher-growth snack brands like Simple Mills. A sale could raise cash and simplify the business, but it also removes a $400 million revenue stream, so the market impact is uncertain.
It is a major strategic action that could reshape the company and affect its value, though the outcome is not yet clear.